0000950123-22-011472.txt : 20221110 0000950123-22-011472.hdr.sgml : 20221110 20221110163505 ACCESSION NUMBER: 0000950123-22-011472 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221110 DATE AS OF CHANGE: 20221110 EFFECTIVENESS DATE: 20221110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 221377892 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 09-30-2022 09-30-2022 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Max Eisenberg (415) 801-8100 /s/ Max Eisenberg San Francisco CA 11-10-2022 0 8 58655 false INFORMATION TABLE 2 18401.xml INFORMATION TABLE FOR FORM 13F Adverum Biotechnologies, Inc. Common Stock 00773U108 4815 5068233 SH OTR 0 5068233 0 Aligos Therapeutics, Inc. Common Stock 01626L105 2552 2320381 SH OTR 0 2320381 0 Clovis Oncology, Inc. Common Stock 189464100 121 101855 SH OTR 0 101855 0 CRISPR Therapeutics AG Common Shares H17182108 32581 498558 SH OTR 0 498558 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 1903 543753 SH OTR 0 543753 0 Gritstone Oncology, Inc. Common Stock 39868T105 9152 3561150 SH OTR 0 3561150 0 Minerva Surgical Inc. Common Stock 60343F106 1331 1673700 SH OTR 0 1673700 0 Passage Bio, Inc. Common Stock 702712100 6200 4959769 SH OTR 0 4959769 0